{"id":117381,"date":"2021-01-29T20:24:32","date_gmt":"2021-01-29T23:24:32","guid":{"rendered":"https:\/\/www.suno.com.br\/noticias\/?p=117381"},"modified":"2021-01-29T20:24:32","modified_gmt":"2021-01-29T23:24:32","slug":"hypera-pharma-hype3-concluiu-compra-takeda","status":"publish","type":"post","link":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/","title":{"rendered":"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda"},"content":{"rendered":"<p>A maior empresa farmac\u00eautica brasileira <a href=\"https:\/\/www.suno.com.br\/acoes\/hype3\/\"><strong>Hypera<\/strong> Pharma (HYPE3),<\/a> informou ao mercado nesta sexta-feira (29) que concluiu a aquisi\u00e7\u00e3o do portf\u00f3lio selecionado de medicamentos isentos de prescri\u00e7\u00e3o na Am\u00e9rica Latina da Takeda Pharmaceuticals International.<\/p>\t<div class=\"wrapper-featured-image\">\n\t\t<figure class=\"spotlightImg\">\n\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 768px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-400x200.webp\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"newsContent__article__imgCapa lazyloadDisabled \" src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp\" width=\"800\" height=\"450\" alt=\"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda\" fetchpriority=high \/>\n\t\t\t<\/picture>\n\n\t\t\t<figcaption class=\"wp-caption-text wp-caption-text--show\">Hypera Pharma (HYPE3) concluiu compra da \u00e1rea da Takeda <\/figcaption>\n\t\t<\/figure>\n\t<\/div>\n\n\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-controle-gastos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Planilha-controle-de-gastos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t\tdata-promo-id=\"101751\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Planilha-controle-de-gastos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>Al\u00e9m disso, &#8220;simultaneamente \u00e0 aquisi\u00e7\u00e3o dos Ativos, foi conclu\u00edda a venda do portf\u00f3lio de 12 selecionados produtos farmac\u00eauticos de prescri\u00e7\u00e3o e OTC naArgentina, Col\u00f4mbia, Equador, M\u00e9xico, Panam\u00e1 e Peru \u00e0 Eurofarma Laborat\u00f3rios bem como a venda do produto \u201cXantinon\u201d \u00e0 Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional&#8221;, informou a Hypera.<\/p>\n<p>Com a conclus\u00e3o dessa opera\u00e7\u00e3o, a Hypera Pharma refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado de OTC, passando a deter duas das tr\u00eas maiores marcas de medicamentos OTC do Brasil, de acordo com o IQVIA.<\/p>\n<p><a href=\"https:\/\/lp.suno.com.br\/suno-one\/\">Suno One: acesse gratuitamente eBooks, Minicursos, Artigos e Video Aulas sobre investimentos com um \u00fanico cadastro. Clique para saber mais!<\/a><\/p>\n<h2>Hypera Pharma investir\u00e1 R$ 2 bilh\u00f5es em f\u00e1brica em Goi\u00e1s<\/h2>\n<p>A\u00a0<strong>Hypera<\/strong> Pharma divulgou seu plano de investimentos de R$ 2 bilh\u00f5es pelos pr\u00f3ximos cinco anos, para aumentar a capacidade de produ\u00e7\u00e3o na sua empresa Brainfarma, em Goi\u00e1s. O an\u00fancio aconteceu na \u00faltima sexta-feira (22) durante a inaugura\u00e7\u00e3o da nova unidade de fabrica\u00e7\u00e3o de medicamentos s\u00f3lidos da companhia.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/ebook-como-analisar-uma-acao\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Mobile.jpg\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop.jpg\"\n\t\t\t\t\tdata-promo-id=\"378302\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='286'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/Ebook-Acoes-Desktop.jpg\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n<p>A Hypera explicou que os investimentos ser\u00e3o destinados para ajustes na produ\u00e7\u00e3o, uma vez que fechou a compra do portf\u00f3lio de rem\u00e9dios da Takeda.<\/p>\n<p>A planta em An\u00e1polis, Goi\u00e1s, tem capacidade para produzir mais de 800 itens. Entretanto, a farmac\u00eautica n\u00e3o especificou em quanto a capacidade de produ\u00e7\u00e3o deve aumentar ap\u00f3s o investimento.<\/p>\n\t<div data-element=\"shortcode-read-more\" class=\"knowMore\">\n\t\t\t\t<span class=\"knowMore__title\">Veja tamb\u00e9m<\/span>\n\t\t\t\t<a class=\"knowMore__link\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-hype3-investira-fabrica-goias\/\">\n\t\t\tHypera Pharma (HYPE3) investir\u00e1 R$ 2 bilh\u00f5es em f\u00e1brica em Goi\u00e1s\t\t<\/a>\n\t<\/div>\n\n\n<p>Em comunicado, a companhia destacou que &#8220;o valor ser\u00e1 destinado \u00e0 expans\u00e3o das opera\u00e7\u00f5es da empresa na cidade de An\u00e1polis e deve gerar 2 mil novos empregos diretos na maior unidade industrial farmac\u00eautica da Am\u00e9rica Latina&#8221;.<\/p>\n<p>&#8220;Desde o ano passado, a empresa j\u00e1 vem investindo em aumento de capacidade para fazer frente n\u00e3o s\u00f3 ao crescimento do mercado farmac\u00eautico brasileiro, mas tamb\u00e9m \u00e0 futura transfer\u00eancia da produ\u00e7\u00e3o para Goi\u00e1s de neg\u00f3cios adquiridos pela <strong>Hypera Pharma<\/strong> desde o final de 2019&#8243;, destacou o comunicado.<\/p>\n<h2>\u00daltima cota\u00e7\u00e3o da HYPE3<\/h2>\n<p>A a\u00e7\u00e3o da <strong>Hypera (HYPE3)<\/strong> encerrou esta sexta-feira em queda de 5,58%, valendo R$ 32,29.<\/p>\n\t<p>\n\t\t<a href=\"https:\/\/lp.suno.com.br\/planilha-de-controle-de-investimentos\/\" target=\"_blank\" data-element=\"shortcode-suno-banner\" title=\"Banner SUNO, clique e saiba mais\">\n\t\t\t<picture>\n\t\t\t\t<source media=\"(max-width: 500px)\" srcset=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/400x300-Controle-de-Investimentos.png\">\n\t\t\t\t<img class=\"newsContent__article__imgCapa newsContent__article__imgCapa--banner\"\n\t\t\t\t\tsrc=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t\tdata-promo-id=\"75934\"\t\t\t\t\t\t\t\t\t\twidth='1420' height='240'\t\t\t\t\talt=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2023\/03\/1420x240-Controle-de-Investimentos.png\"\n\t\t\t\t>\n\t\t\t<\/picture>\n\t\t<\/a>\n\t<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>A maior empresa farmac\u00eautica brasileira Hypera Pharma (HYPE3), informou ao mercado nesta sexta-feira (29) que concluiu a aquisi\u00e7\u00e3o do portf\u00f3lio selecionado de medicamentos isentos de prescri\u00e7\u00e3o na Am\u00e9rica Latina da Takeda Pharmaceuticals International. Hypera Pharma (HYPE3) concluiu compra da \u00e1rea da Takeda Al\u00e9m disso, &#8220;simultaneamente \u00e0 aquisi\u00e7\u00e3o dos Ativos, foi conclu\u00edda a venda do portf\u00f3lio [&hellip;]<\/p>\n","protected":false},"author":56,"featured_media":117388,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[64],"tags":[501],"suno_strategy":[],"class_list":["post-117381","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-negocios","tag-hypera-pharma-hype3"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda<\/title>\n<meta name=\"description\" content=\"Com a aquisi\u00e7\u00e3o, a Hypera refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado. Clique aqui para saber mais.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda\" \/>\n<meta property=\"og:description\" content=\"Com a aquisi\u00e7\u00e3o, a Hypera refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado. Clique aqui para saber mais.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\" \/>\n<meta property=\"og:site_name\" content=\"Suno Not\u00edcias\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/sunoresearch\" \/>\n<meta property=\"og:image\" content=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rafaela La Regina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:site\" content=\"@sunoresearch\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rafaela La Regina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\"},\"author\":{\"name\":\"Rafaela La Regina\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/e672ca8cea627fe715fa29bca7da95e0\"},\"headline\":\"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda\",\"datePublished\":\"2021-01-29T23:24:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\"},\"wordCount\":436,\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp\",\"keywords\":[\"Hypera Pharma (HYPE3)\"],\"articleSection\":[\"Neg\u00f3cios\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\",\"name\":\"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda\",\"isPartOf\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp\",\"datePublished\":\"2021-01-29T23:24:32+00:00\",\"description\":\"Com a aquisi\u00e7\u00e3o, a Hypera refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado. Clique aqui para saber mais.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp\",\"width\":800,\"height\":450,\"caption\":\"Hypera Pharma (HYPE3) concluiu compra da \u00e1rea da Takeda\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neg\u00f3cios\",\"item\":\"https:\/\/www.suno.com.br\/noticias\/negocios\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#website\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"name\":\"Suno Not\u00edcias\",\"description\":\"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos\",\"publisher\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#organization\",\"name\":\"Suno Not\u00edcias\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"contentUrl\":\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png\",\"width\":180,\"height\":180,\"caption\":\"Suno Not\u00edcias\"},\"image\":{\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/facebook.com\/sunoresearch\",\"https:\/\/x.com\/sunoresearch\",\"https:\/\/www.instagram.com\/suno\",\"https:\/\/www.linkedin.com\/company\/suno-research\/\",\"https:\/\/www.youtube.com\/c\/sunoresearch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/e672ca8cea627fe715fa29bca7da95e0\",\"name\":\"Rafaela La Regina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d2c75a52d243deb93d0465fdcb21bd37?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d2c75a52d243deb93d0465fdcb21bd37?s=96&r=g\",\"caption\":\"Rafaela La Regina\"},\"description\":\"Estagi\u00e1ria no Suno Not\u00edcias. Escreve sobre economia, pol\u00edtica e neg\u00f3cios. Estuda Rela\u00e7\u00f5es Internacionais no IBMEC-SP.\",\"url\":\"https:\/\/www.suno.com.br\/noticias\/author\/rafaela-la-regina\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda","description":"Com a aquisi\u00e7\u00e3o, a Hypera refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado. Clique aqui para saber mais.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/","og_locale":"pt_BR","og_type":"article","og_title":"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda","og_description":"Com a aquisi\u00e7\u00e3o, a Hypera refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado. Clique aqui para saber mais.","og_url":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/","og_site_name":"Suno Not\u00edcias","article_publisher":"https:\/\/facebook.com\/sunoresearch","og_image":[{"width":800,"height":450,"url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1.jpg","type":"image\/jpeg"}],"author":"Rafaela La Regina","twitter_card":"summary_large_image","twitter_creator":"@sunoresearch","twitter_site":"@sunoresearch","twitter_misc":{"Escrito por":"Rafaela La Regina","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#article","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/"},"author":{"name":"Rafaela La Regina","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/e672ca8cea627fe715fa29bca7da95e0"},"headline":"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda","datePublished":"2021-01-29T23:24:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/"},"wordCount":436,"publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp","keywords":["Hypera Pharma (HYPE3)"],"articleSection":["Neg\u00f3cios"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/","url":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/","name":"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda","isPartOf":{"@id":"https:\/\/www.suno.com.br\/noticias\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage"},"thumbnailUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp","datePublished":"2021-01-29T23:24:32+00:00","description":"Com a aquisi\u00e7\u00e3o, a Hypera refor\u00e7ar\u00e1 seu portf\u00f3lio de produtos de prescri\u00e7\u00e3o e ampliar\u00e1 sua lideran\u00e7a no mercado. Clique aqui para saber mais.","breadcrumb":{"@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#primaryimage","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-jpg.webp","width":800,"height":450,"caption":"Hypera Pharma (HYPE3) concluiu compra da \u00e1rea da Takeda"},{"@type":"BreadcrumbList","@id":"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.suno.com.br\/noticias\/"},{"@type":"ListItem","position":2,"name":"Neg\u00f3cios","item":"https:\/\/www.suno.com.br\/noticias\/negocios\/"},{"@type":"ListItem","position":3,"name":"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda"}]},{"@type":"WebSite","@id":"https:\/\/www.suno.com.br\/noticias\/#website","url":"https:\/\/www.suno.com.br\/noticias\/","name":"Suno Not\u00edcias","description":"Seu portal de informa\u00e7\u00e3o sobre o mundo dos investimentos","publisher":{"@id":"https:\/\/www.suno.com.br\/noticias\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.suno.com.br\/noticias\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.suno.com.br\/noticias\/#organization","name":"Suno Not\u00edcias","url":"https:\/\/www.suno.com.br\/noticias\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/","url":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","contentUrl":"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/09\/suno-logo.png","width":180,"height":180,"caption":"Suno Not\u00edcias"},"image":{"@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/sunoresearch","https:\/\/x.com\/sunoresearch","https:\/\/www.instagram.com\/suno","https:\/\/www.linkedin.com\/company\/suno-research\/","https:\/\/www.youtube.com\/c\/sunoresearch"]},{"@type":"Person","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/e672ca8cea627fe715fa29bca7da95e0","name":"Rafaela La Regina","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.suno.com.br\/noticias\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d2c75a52d243deb93d0465fdcb21bd37?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d2c75a52d243deb93d0465fdcb21bd37?s=96&r=g","caption":"Rafaela La Regina"},"description":"Estagi\u00e1ria no Suno Not\u00edcias. Escreve sobre economia, pol\u00edtica e neg\u00f3cios. Estuda Rela\u00e7\u00f5es Internacionais no IBMEC-SP.","url":"https:\/\/www.suno.com.br\/noticias\/author\/rafaela-la-regina\/"}]}},"default_loop_html":"<div class=\"cardsPage__listCard__boxs\"><div class=\"cardsPage__listCard__boxs__img\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\"><img class=\"mask\" src=\"https:\/\/www.suno.com.br\/noticias\/wp-content\/themes\/suno\/resources\/images\/spotlight\/spotlight1img\/bg-mask.png\" alt=\"Image Mask\"\/><img src=\"https:\/\/files.sunoresearch.com.br\/n\/uploads\/2021\/01\/477bac07-hyphera-800x450-1-400x200.webp\" alt=\"Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda\"\/><\/a><span class=\"spotlightCategory\"><a href=\"https:\/\/www.suno.com.br\/noticias\/negocios\/\">Neg\u00f3cios<\/a><\/span><\/div><div class=\"cardsPage__listCard__boxs__content\"><a href=\"https:\/\/www.suno.com.br\/noticias\/hypera-pharma-hype3-concluiu-compra-takeda\/\"><h2 class=\"content__title\">Hypera Pharma (HYPE3) concluiu compra de \u00e1rea da Takeda<\/h2><\/a><div class=\"newsContent__article__meta\"><div class=\"newsContent__article__meta__authorBox\"><a href=\"https:\/\/www.suno.com.br\/noticias\/author\/rafaela-la-regina\/\" class=\"authorBox__avatar noMobi\"><img src=\"https:\/\/secure.gravatar.com\/avatar\/d2c75a52d243deb93d0465fdcb21bd37?s=96&#038;r=g\" alt=\"Rafaela La Regina\"><\/a><div class=\"authorBox__name\"><span>por\n\t\t\t<a href=\"https:\/\/www.suno.com.br\/noticias\/author\/rafaela-la-regina\/\"><span itemprop=\"author\">Rafaela La Regina<\/span><\/a><\/span><time datetime=\"2021-01-29T20:24:32-03:00\" itemprop=\"datePublished\">29\/01\/2021 20:24<\/time><\/div><\/div><\/div><\/div><\/div>","single_layout":"posts","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/117381"}],"collection":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/users\/56"}],"replies":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/comments?post=117381"}],"version-history":[{"count":0,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/posts\/117381\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media\/117388"}],"wp:attachment":[{"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/media?parent=117381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/categories?post=117381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/tags?post=117381"},{"taxonomy":"suno_strategy","embeddable":true,"href":"https:\/\/www.suno.com.br\/noticias\/wp-json\/wp\/v2\/suno_strategy?post=117381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}